About Endoplasmic reticulum lectin 1
Endoplasmic reticulum lectin 1 (ERLEC1) is a protein
from Homo sapiens identified by UniProt accession
Q96DZ1, 483 residues long.
MolForge cross-references it against 0 known binders and
58 disease associations.
Target properties
| Protein name | Endoplasmic reticulum lectin 1 |
| UniProt accession | Q96DZ1 |
| Gene | ERLEC1 |
| Organism | Homo sapiens |
| Length | 483 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (58)
Diseases linked to this target (Open Targets).
- holoprosencephaly · score 0.50
- cystic fibrosis · score 0.46
- reticulocyte count · score 0.40
- Mandibular prognathia · score 0.37
- mean corpuscular volume · score 0.33
- lymphocyte count · score 0.33
- pulse pressure measurement · score 0.31
- Red cell distribution width · score 0.31
- hemoglobin measurement · score 0.30
- mean reticulocyte volume · score 0.30
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96DZ1-F1 | alphafold | PREDICTED | 72.96 | — |
Amino-acid sequence (483 residues)
MEEGGGGVRS LVPGGPVLLV LCGLLEASGG GRALPQLSDD IPFRVNWPGT EFSLPTTGVL YKEDNYVIMT TAHKEKYKCI LPLVTSGDEE EEKDYKGPNP RELLEPLFKQ SSCSYRIESY WTYEVCHGKH IRQYHEEKET GQKINIHEYY LGNMLAKNLL FEKEREAEEK EKSNEIPTKN IEGQMTPYYP VGMGNGTPCS LKQNRPRSST VMYICHPESK HEILSVAEVT TCEYEVVILT PLLCSHPKYR FRASPVNDIF CQSLPGSPFK PLTLRQLEQQ EEILRVPFRR NKEEDLQSTK EERFPAIHKS IAIGSQPVLT VGTTHISKLT DDQLIKEFLS GSYCFRGGVG WWKYEFCYGK HVHQYHEDKD SGKTSVVVGT WNQEEHIEWA KKNTARAYHL QDDGTQTVRM VSHFYGNGDI CDITDKPRQV TVKLKCKESD SPHAVTVYML EPHSCQYILG VESPVICKIL DTADENGLLS LPN
Explore Endoplasmic reticulum lectin 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets